ISSUES: Comorbidity between anxiety and substance use disorders is common, yet it is poorly understood and poorly treated. APPROACH: Narrative literature review. PsycINFO and Medline databases were searched for clinical trials of anxiety and substance use disorders using clinical queries for 2005-2009. KEY FINDINGS: There are few well-conducted treatment outcome trials for comorbid anxiety and substance use disorders. Some recent (2005-2009) outcome literature has focused on specific mechanisms (anxiety sensitivity and tension reduction alcohol expectancies) that may underlie comorbidity between anxiety and substance use disorders and may lead to more targeted intervention. IMPLICATIONS AND CONCLUSION: The research base for understanding and treating comorbid anxiety and substance use disorders needs to be broadened. In particular research is needed with a focus on: (i) specifying particular comorbid relationships between anxiety and substance use disorders; (ii) the mechanisms that may underlie and maintain those relationships; and (iii) well-conducted evaluations of treatments that target those mechanisms.
ISSUES: Comorbidity between anxiety and substance use disorders is common, yet it is poorly understood and poorly treated. APPROACH: Narrative literature review. PsycINFO and Medline databases were searched for clinical trials of anxiety and substance use disorders using clinical queries for 2005-2009. KEY FINDINGS: There are few well-conducted treatment outcome trials for comorbid anxiety and substance use disorders. Some recent (2005-2009) outcome literature has focused on specific mechanisms (anxiety sensitivity and tension reduction alcohol expectancies) that may underlie comorbidity between anxiety and substance use disorders and may lead to more targeted intervention. IMPLICATIONS AND CONCLUSION: The research base for understanding and treating comorbid anxiety and substance use disorders needs to be broadened. In particular research is needed with a focus on: (i) specifying particular comorbid relationships between anxiety and substance use disorders; (ii) the mechanisms that may underlie and maintain those relationships; and (iii) well-conducted evaluations of treatments that target those mechanisms.
Authors: Maartje Luijten; Marise W J Machielsen; Dick J Veltman; Robert Hester; Lieuwe de Haan; Ingmar H A Franken Journal: J Psychiatry Neurosci Date: 2014-05 Impact factor: 6.186
Authors: S Patricia Chou; Hae K Lee; Maeng J Cho; Jong-Ik Park; Deborah A Dawson; Bridget F Grant Journal: Alcohol Clin Exp Res Date: 2011-09-15 Impact factor: 3.455
Authors: Mor Yehudai; Shmaya Bender; Valentina Gritsenko; Vsevolod Konstantinov; Alexander Reznik; Richard Isralowitz Journal: Int J Ment Health Addict Date: 2020-07-06 Impact factor: 3.836
Authors: Melexima Simirea; Cédric Baumann; Michael Bisch; Hélène Rousseau; Paolo Di Patrizio; Sarah Viennet; Stéphanie Bourion-Bédès Journal: Health Qual Life Outcomes Date: 2022-02-16 Impact factor: 3.186
Authors: J Sarris; S Moylan; D A Camfield; M P Pase; D Mischoulon; M Berk; F N Jacka; I Schweitzer Journal: Evid Based Complement Alternat Med Date: 2012-08-27 Impact factor: 2.629